October 12, 2021 | Diversity, Equality, clinical trials, lupus, lupusawareness, patient recruitment
In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.
October marks Lupus Awareness month in which education and awareness of lupus is brought to light through several initiatives. Lupus is an autoimmune disease as it causes the immune system to attack healthy cells in the body.
It has been long established that 90% of individuals with lupus are women, with the illness being up to three times more prevalent in women of colour than Caucasian women. Moreover, Lupus has been previously ranked amongst the top 20 causes of death in all women, however this figure rose to distressing new levels as lupus is now recognized as the 5th and 6th leading cause of death among Black and Hispanic women aged 15-34.
Read the full blog here
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
See how Innovative Trials supported a Top 5 pharma to complete enrollment in a Phase 2 Lupus study
Innnovative Trials’ Equality & Diversity committee celebrates Pride Month
Discover how community engagement could enhance diversity in clinical trials patient recruitment
Innovative Trials, a global clinical trial patient recruitment and retention company based in Hertfordshire, has been recognised for its contribution to the county’s economy and business reputation.
For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in…
Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.
Eloise Moffett joins Innovative Trials as New Vice President of Commercial to drive business growth globally
The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five…
Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients – and therefore more robust…
Kate Shaw, Innovative Trials’ Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
